SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activationArticle Published on 2023-03-012023-07-11 Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), [키워드] Acute kidney injury COVID-19 Inflammation NF-κB ORF3a Phosphorylation renal tubule SARS-CoV-2 STAT zebrafish. [DOI] 10.1016/j.ymthe.2022.12.008 PMC 바로가기
The Spike protein of SARS-CoV-2 signals via Tlr2 in zebrafishArticle Published on 2023-03-012023-07-11 Journal: Developmental and comparative immunology [Category] COVID19(2023년), [키워드] Hematopoiesis Inflammation interleukin-1 Spike protein TLRs zebrafish. [DOI] 10.1016/j.dci.2022.104626 PMC 바로가기
The Impact of COVID-19 Infection on Miscellaneous Inflammatory Disorders of the Gastrointestinal TractReview Published on 2023-03-012023-07-11 Journal: Gastroenterol Clin North Am : book_id PMC인데 pubmed로 기재 [Category] COVID19(2023년), [키워드] COVID-19 Gastrointestinal Inflammation pandemic SARS. [DOI] 10.1016/j.gtc.2022.10.002 PMC 바로가기 [Article Type] Review
ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunityArticle Published on 2023-02-212023-06-14 Journal: Frontiers in Immunology [Category] Fulltext, 신종인플루엔자, [키워드] Endothelium Inflammation Integrins leukocyte trafficking memory. [DOI] 10.3389/fimmu.2022.1041552 PMC 바로가기
The synergistic effect and mechanisms of flavonoids and polysaccharides from Houttuynia cordata on H1N1-induced pneumonia in miceArticle Published on 2023-02-102023-06-24 Journal: Journal of ethnopharmacology [Category] 신종인플루엔자, [키워드] flavonoids Inflammation Influenza polysaccharides Synergy. [DOI] 10.1016/j.jep.2022.115761 PMC 바로가기
ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular CarcinomaArticle Published on 2023-02-052023-06-12 Journal: International Journal of Molecular Sciences [Category] B형 간염, [키워드] Immunotherapy Inflammation Liver cancer tumor microenvironment. ZNF346 ZNF385A [DOI] 10.3390/ijms24043155 PMC 바로가기
Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathwayArticle Published on 2023-01-302022-11-15 Journal: Journal of ethnopharmacology [Category] 유전자 메커니즘, 진단, [키워드] Activation acute lung injury ALI model alleviate analysis Analysis attenuate Baidu caused Cell cellular China component Component analysis components Compound COVID-19 COVID-19 patients demonstrated experiment experimental validation Formula in vivo increases in indicated Inflammation ingredient inhibited inhibiting Kyoto lung Lung injury material mechanism of action Mild molecular mechanism network network pharmacology NF-κB pathway NF-κB signaling NF-κB signaling pathway Obstructive Ontology p-NF-κB p65 pathway pharmacological predicted proinflammatory Proteins reduced syndrome target treat Treatment Xuanfei baidu formula. [DOI] 10.1016/j.jep.2022.115833 PMC 바로가기
PI3K/AKT-mediated autophagy inhibition facilitates mast cell activation to enhance severe inflammatory lung injury in influenza A virus- and secondary Staphylococcus aureus-infected miceArticle Published on 2023-01-012023-06-24 Journal: Antiviral Research [Category] 신종인플루엔자, [키워드] autophagy Inflammation influenza A virus mast cell secondary bacterial infection. [DOI] 10.1016/j.antiviral.2022.105502 PMC 바로가기
Hematological characteristics of COVID-19 patients with fever infected by the Omicron variant in Shanghai: A retrospective cohort study in ChinaArticle Published on 2023-01-012023-07-11 Journal: Journal of Clinical Laboratory Analysis [Category] COVID19(2023년), [키워드] Coronavirus disease 2019 differential diagnosis hematological parameters Inflammation Severe acute respiratory syndrome coronavirus 2. [DOI] 10.1002/jcla.24808 PMC 바로가기
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trialRandomized Controlled Trial Published on 2023-01-012023-07-10 Journal: European journal of internal medicine [Category] COVID19(2023년), [키워드] anti-IL-1 Colchicine coronavirus COVID-19 Inflammation SARS-CoV-2. [DOI] 10.1016/j.ejim.2022.10.016 PMC 바로가기 [Article Type] Randomized Controlled Trial